Artivion | CRY - Stock


Artivion reported $103.36M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
Accuray USD 150.96M 4.54M Dec/2025
AngioDynamics USD 65.57M 3.56M Sep/2025
Artivion USD 103.36M 5.37M Jun/2026
AtriCure USD 83.92M 2.78M Jun/2026
Baxter International USD 2.26B 57M Jun/2026
Becton, Dickinson and Co. USD 3.32B 41M Jun/2026
Boston Scientific USD 3.24B 118M Jun/2026
Edwards Lifesciences USD 1.13B 12.2M Jun/2026
Inogen USD 25.08M 762K Sep/2025
Integra LifeSciences USD 492M 3.03M Jun/2026
J&J USD 15.14B 561M Jun/2026
Mesa Laboratories USD 26.56M 1.18M Dec/2025
Orthofix International USD 184.48M 6.66M Jun/2026
Pfizer USD 9.94B 722M Jun/2026
ResMed USD 945.8M 33.93M Jun/2026
Stryker USD 5.52B 102M Jun/2026
Tandem Diabetes Care USD 135.11M 8.71M Jun/2026
Teleflex USD 351.91M 28.95M Jun/2026
Terumo JPY 335.63B 23.72B Mar/2026
Trinity Biotech USD 18.83M 332K Dec/2025